Introducing our cutting-edge Gyrolab Immunoassay system, a revolutionary solution for high-throughput immunoassay analysis. This advanced technology offers unmatched performance and efficiency, making it the perfect choice for pharmaceutical, biotech, and research laboratories. The Gyrolab Immunoassay system is designed to streamline the immunoassay process, delivering rapid and precise results with minimal hands-on time. Its compact design and fully automated operation make it ideal for labs with limited space and resources, allowing for seamless integration into existing workflows. With the Gyrolab Immunoassay system, researchers can achieve unparalleled sensitivity and accuracy, enabling the detection of low-abundance biomarkers and the quantification of target analytes with confidence. Its unique microfluidic technology and continuous flow processing ensure excellent reproducibility and reliability, even when handling complex sample matrices. In addition to its exceptional performance, the Gyrolab Immunoassay system offers unparalleled flexibility, allowing for the simultaneous analysis of multiple analytes and sample types. This versatility, combined with its rapid assay development capabilities, makes it a valuable asset for a wide range of applications, from pharmacokinetics and toxicology studies to biomarker discovery and validation. We are proud to bring this innovative technology to the market, empowering researchers to accelerate their immunoassay workflows and advance their scientific discoveries. Discover the future of immunoassay analysis with the Gyrolab Immunoassay system.

Beijing, China - In a groundbreaking development, researchers at Beijing Beier Bioengineering Co., Ltd. have announced a major breakthrough in the fight against Treponema Pallidum, the bacterium that

Beijing Beier Bioengineering Co., Ltd., a high-tech enterprise in China specializing in the development and production of in vitro diagnostic reagents, has recently introduced a new Rtk Antigen Self T